rood blauwe elepsis logo Belegger.nl

Koffiekamer Terug naar discussie overzicht

Trading idee Hollywood staking

5 Posts
| Omlaag ↓
  1. Remco9384 20 juli 2023 18:44
    Hollywood staakt en dat raakt sommige bedrijven. Stakingen gaan uiteindelijk allemaal voorbij. Er zijn beursgenoteerde bedrijven die waarschijnlijk flink hoger zullen noteren als de staking eindigt.
    Het in Londen genoteerde Zoo Digital lijkt in dat opzicht een prima trading kans. Zoo digital is dienstverlener aan streamingdiensten. Na de trading update waarin het bedrijf meldde last te hebben van de staking verloor het 50 procent in 2 dagen, en het aandeel zit al sinds mei in een flinke downtrend.
    Dit is geen bedrijf met faillisementsrisico's en er wordt gewoon geld verdient. Verder is er dit jaar nog een emissie geweest om overnames te financieren. Zowel institutionele investeerders als particulieren hebben toen 160 pence per nieuw aandeel betaald. De huidige koers is 63 pence.
  2. Remco9384 26 juli 2023 19:43
    Na meerdere keren de 59 pence te hebben aangetikt, vandaag een serieuze stijging van 11 procent. Het voorsorteren op verbeterde omstandigheden is begonnen.
  3. Remco9384 2 augustus 2023 11:13
    Vandaag te koop voor 66 pence

    Zoo Digital Group (LSE:ZOO) Price Target Decreased by 37.65% to 171.70

    The average one-year price target for Zoo Digital Group (LSE:ZOO) has been revised to 171.70 / share. This is an decrease of 37.65% from the prior estimate of 275.40 dated July 5, 2023.

    The price target is an average of many targets provided by analysts. The latest targets range from a low of 156.55 to a high of 189.00 / share. The average price target represents an increase of 141.83% from the latest reported closing price of 71.00 / share.
  4. Remco9384 10 augustus 2023 09:18
    ZOO Digital | Final Results FY23 Announcement
    View in browser
    ZOO Digital
    Results-FY23
    FINAL RESULTS FOR THE YEAR ENDED 31 MARCH 2023


    ZOO Digital Group plc (AIM: ZOO), the leading provider of end-to-end (“E2E”) cloud-based localisation and media services to the global entertainment industry, today announces its audited financial results for the year ended 31 March 2023.



    A presentation for retail investors will be live streamed on Thursday 10th August at 5:00pm GMT. For those interested in joining, please register via the following link.



    Full Year Results Video
    Watch the results summary
    Highlights

    Key Financials

    Revenue grew by 28% to $90.3 million (FY22: $70.4 million).
    3% of sales were from newly acquired operations.
    Adjusted EBITDA* grew to $15.5 million (FY22 restated: $7.1 million).
    EBITDA* margin increased to 17.1% (FY22 restated: 10.0%).
    Operating profit has quadrupled to $8.1 million (FY22 restated: $1.9 million).
    Reported profit before tax of $7.9 million (FY22 loss restated: $0.2 million).
    Net cash generated from operations up 197% to $15.5 million (FY22: $5.2 million).
    Net cash at year-end of $11.8 million (FY22: $6.0 million).
    * Adjusted for share-based payments



    Operational Highlights

    ZOO selected as a key vendor by a second major content producer with ZOOstudio adopted to support its content localisation across vendors.
    Media localisation segment sales grew by 34% to $56.6 million (FY22: $42.2 million) – subtitling increased by 15% and dubbing by 73%.
    Media services grew by 22% to $32.1 million (FY22: $26.4 million).
    Worldwide freelancer network grew by 4% to 11,467 (FY22: 11,028).
    Leading standard of customer satisfaction maintained – retained sales KPI was 98.5% (FY22: 97.6%).
    Strong progress in global growth initiative with further investments across hubs in India, South Korea, Denmark and Spain.
    Broader Market Highlights

    Global content investment totalled $238 billion in 2022 and is forecast to reach $242 billion in 2023.
    Non-English digital originals grew from 5.9% to 8.5% as a percentage of the total demand for streaming original shows in the period 2020 to 2022.
    Media localisation spend with major suppliers estimated by Nimdzi to have grown by more than 280% between 2018 and 2022, from $420 million to $1.6 billion.
    Outlook and Post Period events

    Raised £12.5 million gross ($15.5 million) via an oversubscribed placing in April 2023 to fund the proposed acquisition of a partner company in Japan with which ZOO continues to have positive, advanced discussions.
    Current trading has been impacted by several major streaming companies carrying out strategic reviews to refocus on profitability and the first simultaneous strike of US writers and actors in 60 years. This has created short-term market disruption and temporarily lower volumes of localisation and media services work.
    The Board has been taking steps to adjust the cost base to reduce the impact of the temporary industry slow-down on ZOO’s business while there remains uncertainty around the timing of the resumption of former levels of production and orders. The Group remains financially strong with net cash at 30 June 2023 of $23 million.
    ZOO expects to emerge in an even stronger position once certain customers have rationalised their supplier bases, resulting in ZOO taking further market share once former order levels resume. It is reasonable to expect this will be in H2 FY24.
    The Board remains confident in ZOO’s medium and long-term fundamentals and expects to deliver revenue growth over FY23 in the following years. Our guidance for FY24 remains unchanged and our 2030 strategy remains on track.
5 Posts
|Omhoog ↑

Neem deel aan de discussie

Word nu gratis lid van Belegger.nl

Al abonnee? Log in

Direct naar Forum

Zoek alfabetisch op forum

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
Forum # Topics # Posts
Aalberts 466 7.072
AB InBev 2 5.521
Abionyx Pharma 2 29
Ablynx 43 13.356
ABN AMRO 1.582 51.741
ABO-Group 1 22
Acacia Pharma 9 24.692
Accell Group 151 4.132
Accentis 2 267
Accsys Technologies 23 10.753
ACCSYS TECHNOLOGIES PLC 218 11.686
Ackermans & van Haaren 1 191
ADMA Biologics 1 34
Adomos 1 126
AdUX 2 457
Adyen 14 17.754
Aedifica 3 918
Aegon 3.258 322.881
AFC Ajax 538 7.088
Affimed NV 2 6.297
ageas 5.844 109.895
Agfa-Gevaert 14 2.051
Ahold 3.538 74.341
Air France - KLM 1.025 35.082
AIRBUS 1 12
Airspray 511 1.258
Akka Technologies 1 18
AkzoNobel 467 13.042
Alfen 16 24.931
Allfunds Group 4 1.482
Almunda Professionals (vh Novisource) 651 4.251
Alpha Pro Tech 1 17
Alphabet Inc. 1 406
Altice 106 51.198
Alumexx ((Voorheen Phelix (voorheen Inverko)) 8.486 114.822
AM 228 684
Amarin Corporation 1 133
Amerikaanse aandelen 3.837 243.386
AMG 971 133.699
AMS 3 73
Amsterdam Commodities 305 6.697
AMT Holding 199 7.047
Anavex Life Sciences Corp 2 491
Antonov 22.632 153.605
Aperam 92 15.017
Apollo Alternative Assets 1 17
Apple 5 383
Arcadis 252 8.785
Arcelor Mittal 2.034 320.770
Archos 1 1
Arcona Property Fund 1 286
arGEN-X 17 10.326
Aroundtown SA 1 219
Arrowhead Research 5 9.745
Ascencio 1 28
ASIT biotech 2 697
ASMI 4.108 39.268
ASML 1.766 108.099
ASR Nederland 21 4.502
ATAI Life Sciences 1 7
Atenor Group 1 509
Athlon Group 121 176
Atrium European Real Estate 2 199
Auplata 1 55
Avantium 32 13.687
Axsome Therapeutics 1 177
Azelis Group 1 64
Azerion 7 3.404